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Purpose:  Propolis  biological  effects  are  mainly  attributed  to its  polyphenolic  constituents  such  as
ﬂavonoids  and  phenolic  acids  that  were  recently  described  in the  chemical  composition  of an  extract
of  propolis  obtained  with  edible  vegetal  oil (OEP)  by our group.  The  aim of  this  study  was  to evaluate  the
effect  of OEP  on  the behavior  of rats.
Materials  and  methods:  An in  vivo open  ﬁeld  (OF),  elevated  Plus-maze  (EPM),  and  forced  swimming
(FS)  tests  were  performed  to evaluate  locomotor  activity,  anxiolytic-  and  antidepressant  effects  of  the
extract.  Besides,  oxidative  stress  levels  were  measured  in rat  blood  samples  after  the  behavioral  assays
by  evaluation  of the  Trolox  equivalent  antioxidant  capacity  (TEAC)  and  nitric  oxide  levels.
Results:  OEP  increased  locomotion  in  the OF  test  (50  mg/kg)  and  central  locomotion  and  open  arm  entries
in  the  OF  and  EPM  tests  (10–50  mg/kg)  and decreased  the  immobility  time  in  the  FS  test (10–50  mg/kg).
Moreover,  OEP  reduced  nitric  oxide  levels in  response  to swim  stress  induced  in  rats.
Conclusion:  OEP  exerted  stimulant,  anxiolytic  and antidepressant  effects  on the  Central  Nervous  System
and  antioxidant  activity  in rats,  highlighting  propolis  as  a potential  therapeutic  compound  for  behavior
impairment  of anxiety  and  depression.ntroduction
Aqueous or ethanolic extracts of propolis (EEP) are widely used
s alternative medicinal products due to their antimicrobial and
nti-inﬂammatory properties as well as their ability to enhance
odily resistance to illness. In bee hives, propolis is primarily used
o maintain an aseptic environment, which is essential to colony
urvival. Sforcin and Bankova (2011) discussed the potential of
ropolis for the development of new drugs, but there is a sub-
tantial lack of clinical research in pharmacologic studies. Many
tudies have reported the antimicrobial, antioxidant, anti-tumor,
nd anti-inﬂammatory effects of propolis (Menezes, 2005; Alencar
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et al., 2007; Carvalho et al., 2011). However, the effect(s) of propo-
lis on the Central Nervous System (CNS), such as depressant and
anxiolytic effects, have been poorly reported.
Several studies have reported pharmacological activities asso-
ciated with the EEP. Indeed, recent studies reported that the oil
extract of Brazilian propolis (OEP) had antifungal and antibac-
terial activities, mainly against Gram-positive bacteria in vitro
(Buriol et al., 2009; Finger et al., 2013) and anti-tumoral activ-
ity in mice in vivo (Carvalho et al., 2011). Concerning its effect
on the CNS, several studies have suggested that the EEP and
its phenolic compounds have neuroprotective effects in both
in vitro and in vivo models (Amodio et al., 2003; Kwon et al.,
2004; Shimazawa et al., 2005; Liu et al., 2008; Gao  et al., 2008;
Nakajima et al., 2009). Mahmoud et al. (2000), showed that caffeic
acid phenethyl ester (CAPE), a component of propolis, exhibited
neuroprotective effects against oxidative damage in an induced
model of ischemia and in neurodegenerative disorders including
Alzheimer’s disease (Menezes, 2005; Mahmoud et al., 2000; Chen
et al., 2008).
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In addition, in vitro and in vivo studies have shown that propo-
is ﬂavonoids produce neuronal protection against brain damage
nduced by several neurotoxins (for review see Dovichi and Lajolo,
011). The effect can be explained by a dual mechanism, such as the
ntioxidant and anti-inﬂammatory effects of propolis, in models of
lzheimer’s disease (Youdim and Joseph, 2001). Studies suggest
hat ﬂavonoids could be an alternative therapy for neurodegener-
tive disorders due to their ability to modulate neuronal function
Guaraldo et al., 2000; Dhawan et al., 2001; Watanabe et al., 2001;
hawan et al., 2004; Johnston and Beart, 2004). Regular intake of
hese compounds has been shown to improve cognitive functions;
his effect is most likely mediated through protection of neurons
nd/or by improvement of neuronal function (Commenges et al.,
000; Vauzour et al., 2008). Thus, an important point in propo-
is research refers to its antioxidant and CNS properties, including
odiﬁcation of behavior and mood (Guaraldo et al., 2000; Dhawan
t al., 2001, 2004).
Because oil extracts have advantages over the more commonly
sed EEP, especially in terms of ﬂavor, it is important to assess their
harmacological potential. Moreover, recently our group described
he chemical composition of OEP that presents substances with bio-
ogical activity (Finger et al., 2013). In the present study, we  aimed
o investigate, for the ﬁrst time, the effect of the OEP on the CNS
f rats by behavioral tests. Additionally, the antioxidant activity of
EP was evaluated in vivo.
aterials and methods
ropolis origin and extract preparation
Samples: propolis samples were collected in 2006 and supplied
y Campolin & Schmidt Company from Prudentópolis city (Paraná
tate, Brazil). Propolis was stored at −18 ◦C until extraction.
Extracts: Fifty grams of propolis was extracted in a shaker
ith 500 ml  of canola oil for 24 h at room temperature. After that
eriod, the extract was ﬁltered and partitioned in an 80:20 (v/v)
ethanol:water solution. The aqueous methanolic phase was dried
n a rotatory evaporator to yield the OEP as described by Finger et al.
2013).
nimals
Two-month-old female Wistar rats weighing 150–300 g were
btained from the Federal University of Pará (UFPA) and kept in
ollective cages (5 animals per cage). Animals were maintained in a
limate-controlled room with a 12-h reverse light/dark cycle (lights
n 7:00 AM)  and food and water ad libitum.  All procedures were
pproved by the Ethics Committee on Experimental Animals of the
ederal University of Pará under license number BIO-046-12 and
ollowed the guidelines suggested by the NIH Guide for the Care
nd Use of Laboratory Animals.
Oxidative stress evaluation experiments were designed in the In
itro Activities Laboratory, and behavioral assays were performed
n the Laboratory of Pharmacology of Inﬂammation and Behavior at
he Federal University of Pará. After the behavioral assays, the ani-
als were euthanized by cervical displacement. OEP was dissolved
n hydroalcoholic solution plus Tween 80 (5%) and intraperitoneally
i.p.) administered at doses of 10 mg/kg, 30 mg/kg, and 50 mg/kg. All
EP doses were administered 1 h before the behavioral tests. For
he antioxidant analyses, the animals’ blood samples were obtained
y puncturing the retro-orbital plexus.The positive control treatments included diazepam (DZP:
-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-
-one, Diazepamil® from Hipolabor Laboratory, Brazil) and
uoxetine (FXT: N-methyl-3-phenyl-3-[4-(triﬂuoromethyl)e 21 (2014) 1466–1472 1467
phenoxy]propan-1-amine hydrochloride, Fluxene® from Euro-
farma Laboratory, Brazil).
Trolox equivalent antioxidant capacity (TEAC) and nitric oxide
levels were measured in the blood samples of rats treated with
saline (behavioral training stress [BTS] group) or OEP (BTS + OEP)
and subjected to a forced swimming test for 5 min. The control
group animals were not subjected to behavioral activities (basal
group).
Behavioral assays
Animals were divided into ﬁve groups (n = 8–10 animals per
group), deﬁned as follows: A – negative control group (vehicle),
received hydroalcoholic solution plus Tween 80 (5%) i.p.; B – pos-
itive control group, received 10 mg/kg DZP i.p. (anxiety-like tests)
or 10 mg/kg FXT i.p. (depressant-like test); C – received 10 mg/kg
OEP i.p.; D – received 30 mg/kg OEP i.p.; and E – received 50 mg/kg
OEP i.p.
Open ﬁeld (OF) test
OEP, the hydroalcoholic solution plus Tween 80 (5%) or
the DZP were administered 60 min  before the behavioral tests.
Rats were placed individually in the center of a wooden arena
(100 cm × 100 cm × 40 cm)  divided into 25 quadrants to evaluate
the number of sections visited by the animal over a period of 5 min.
The test was videotaped and analyzed by Any Maze Stoelting soft-
ware (USA). The parameters total distance traveled, time spent in
the central area, and number of grooming events were measured
(Zeef et al., 2012). The placement of one, two or three paws in a
square followed by a return to the previous square was not consid-
ered a crossing.
Elevated plus maze (EPM) test
Following the open ﬁeld (OF) test, the animals were subjected to
the elevated plus maze (EPM) test, which consists of a plus-shaped
wooden maze with two  opposite open arms (50 cm × 10 cm)  and
two enclosed arms (50 cm × 10 cm × 40 cm)  spreading out from a
central platform (10 cm × 10 cm)  elevated at a height of 50 cm from
the ﬂoor. The animals were individually placed in the center of
the EPM, facing one of the enclosed arms, and were allowed to
explore the apparatus for 5 min  following the procedure described
by Pellow et al. (1985). The following parameters were measured:
(a) frequency of open arm entries (OAE), (b) frequency of enclosed
arm entries (EAE), (c) open arm time (OAT), and (d) enclosed arm
time (EAT). The %OAE and %OAT were calculated according to the
formula open/total × 100. An entry was  counted whenever the ani-
mal  placed four paws in an arm of the maze. An anxiogenic effect
is deﬁned as a decrease in the % OAE and/or % OAT.
Forced swimming (FS) test
Following the EPM test, the animals were subjected to the forced
swimming (FS) test. Rodents were individually dropped into cylin-
drical tank (50 cm in diameter; 70 cm high) containing water at
23 ± 1 ◦C and were monitored for 5 min  in inescapable conditions.
Immobility time was  recorded during the last 3 min. The ﬁrst 2 min
were considered habituation. The rats were judged as immobile
whenever they stopped swimming and ﬂoated in an upright posi-
tion for 2 s, making only small movements to keep their head
above the water level. An antidepressant-like effect was consid-
ered present when lower immobility was observed compared to
the control group. The number of climbing events was measured to
evaluate motor conditions (Porsolt et al., 1977).
1 edicine 21 (2014) 1466–1472
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Fig. 1. Locomotor activity of rats tested in a wooden arena for 5 min. Each value
represents the mean (S.E.M.) of 8–10 animals (females). Groups: control; oil extract
of  propolis (OEP) at doses of 10 mg/kg, 30 mg/kg, and 50 mg/kg, and diazepam (DZP).468 J.S.S. Reis et al. / Phytom
After the behavioral tests, blood samples were collected for
etermination of oxidative stress.
easurement of total antioxidant status (TAS)
The total antioxidant status (TAS) is a sensitive and reliable
arker for detecting in vivo oxidative stress markers that may  not
e detectable through the measurement of a single, speciﬁc antiox-
dant (Cohen et al., 2009). In this study, rats were pretreated with
EP (10 mg/kg, 30 mg/kg, and 50 mg/kg) or vehicle 60 min  before
he behavioral tests. After the behavioral tests (about 5 h), blood
amples were collected to evaluate TAS by measuring the TEAC lev-
ls using the method developed by Ruﬁno et al. (2007). In this assay,
,2-azinobis (3-ethylbenzothiazoline, 6-sulfonate) (ABTS2) is incu-
ated with persulfate to produce ABTS+. This species is blue-green.
ntioxidants present in the sample cause a reduction in absorption
roportional to their concentration. The antioxidant capacities of
he samples are expressed as TEAC using a calibration curve plotted
ith different amounts of Trolox, and their absorbance measured
t 740 nm (Re et al., 1999)
etermination of serum nitric oxide concentration
The nitrate (NO3−) present in the serum samples was  converted
o nitrite with nitrate reductase, and the nitrite concentration
as determined using the Griess method (Granger et al., 1999).
rieﬂy, 100 l of the supernatant samples was incubated with
n equal volume of Griess reagent for 10 min  at room tempera-
ure. The absorbance was  measured on a plate scanner (Spectra
ax  250; Molecular Devices, Menlo Park, CA, USA) at 550 nm.
he nitrite (NO2−) concentration was determined using a standard
urve generated using sodium nitrite (NaNO2). Nitrite production
s expressed per M.
tatistical analysis
Data were analyzed using one-way analysis of variance (ANOVA)
ollowed by Tukey’s test for multiple comparisons of behavior or
xidative stress test results. p values less than 0.05 (p < 0.05) were
onsidered to be indicative of signiﬁcance.
esults
EP increases ambulation in the OF test
The locomotor activity of each group in the open ﬁeld arena
for 5 min) is summarized in Fig. 1. Acute OEP administration at
0 mg/kg (p < 0.001) increased the distance traveled on the appara-
us, which was similar to that of the positive control DZP (p < 0.001).
ost hoc comparisons indicated that doses below 50 mg/kg of OEP
10 mg/kg and 30 mg/kg) did not alter locomotion.
EP showed an anxiolytic-like effect in experimental models of
nxiety
The effects of acute OEP administration evaluated in the OF
est revealed that propolis increased the percentage of central
uadrants crossed at all doses (10 mg/kg, 30 mg/kg, and 50 mg/kg)
n a dose-dependent manner (Fig. 2, Panel A). One-way ANOVA
evealed that the other anxiety parameters, such as the percent
f time spent in the central area (Fig. 2, Panel B) and the number of
rooming events (Fig. 2, Panel C), were also altered, demonstrating
nxiolytic-like effects at a dose of 50 mg/kg.
Anxiolytic-like effects of OEP were also observed in the EPM
est (Fig. 3). A subsequent Tukey’s test indicated that the open arm
ntries increased for all propolis extract doses tested (Fig. 3, Panel A;*p  < 0.05 compared to the control group treated with hydroalcoholic solution plus
Tween 80 (5%); #p < 0.05 compared to the DZP group; +p < 0.05 compared to the OEP
50  mg/kg group (ANOVA, Tukey’s test).
p < 0.001). However, the time spent in the open arms only increased
at OEP doses higher than 10 mg/kg (Fig. 3, Panel B; p < 0.001 and
p < 0.05, respectively).
OEP presents antidepressant-like effect in rodents
The effect of OEP administration on antidepressant-like activity
evaluated by the FS test is illustrated in Fig. 4. One-way ANOVA
revealed that OEP reduced the immobility time at all doses tested
(Fig. 4, Panel A) without affecting motor parameters such as the
number of climbing events (Fig. 4, Panel B).
OEP showed antioxidant activity in rodents behavioral training
stress
The behavioral training stress group (BTS group) showed an
increase of antioxidant (TAS) and pro-oxidant (NO) parameters
compared to the basal group. The TEAC levels induced in the BTS
group were not altered by pretreatment with any dose of OEP (Fig. 5,
panel A). However, OEP was  able to signiﬁcantly decrease the NO
levels in the serum of BTS-animals treated with doses of 10 mg/kg,
30 mg/kg and 50 mg/kg (Fig. 5, panel B).
Discussion
In the present study, we  investigated whether OEP exerts
behavioral and oxidative stress effects. We  report that acute
OEP administration causes behavioral effects as hyperlocomo-
tion, anxiolytic- and antidepressant-like effects based on speciﬁc
behavioral tests (OF, EPM, and FS). Oxidative biochemical analysis
demonstrates that OEP reverses the negative effects of behavioral
stress.
The pharmacological effects of propolis have been attributed
to the presence of ﬂavonoids, phenolic acids and ester deriva-
tives (Lu et al., 2004), and to the presence of terpenes (Silva
et al., 2005; Albuquerque et al., 2007). Our  research group
recently described the chemical composition of the OEP employed
in the behavioral tests in the present study (Carvalho et al.,
2011; Finger et al., 2013). Carvalho et al. (2011) reported that
this sample of propolis collected in 2006 in Prudentópolis city
(Paraná State, Brazil) presented several constituents that were
identiﬁed by liquid chromatography/electrospray ionization mass
spectrometry in negative-ion (ESI(-)-MS/MS) that provides ﬁn-
gerprinting characterization through its characteristic proﬁles of
J.S.S. Reis et al. / Phytomedicine 21 (2014) 1466–1472 1469
Fig. 2. Central locomotion (panel A), time spent in the central area (panel B), and
number of grooming events (panel C) of rats tested in the wooden arena for 5 min.
Each value represents the mean (S.E.M.) of 8–10 animals (females). Groups: con-
trol; oil extract of propolis (OEP) at doses of 10 mg/kg, 30 mg/kg, and 50 mg/kg; and
diazepam (DZP). *p < 0.05 compared to the control group treated with hydroalco-
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Fig. 3. Percent of open arm entries (panel A), percent of open arm time (panel B)
and  enclosed arm entries (panel C) of rats tested in the elevated plus maze (EPM) for
5  min. Each value represents the mean (S.E.M.) of 8–10 animals (females). Groups:
control; oil extract of propolis (OEP) at doses of 10 mg/kg, 30 mg/kg, and 50 mg/kg;
animals produces anxiolytic-like activity in both the OF and EPMolic solution plus Tween 80 (5%); #p < 0.05 compared to the DZP group; +p < 0.05
ompared to the OEP 50 mg/kg group (ANOVA, Tukey’s test).
heir chemical composition according to the polarity and acidic
r basic components; liquid chromatographic mass spectrome-
ry (LC–MS) and LC–MS/MS that revealed the main constituents:
,4-dihydroxi-5-prenyl-cinnamic acid; dihydrokaempferide; 3-
renyl-4-hydroxycinnamic acid; (E)-3-{-4-hydroxy-3-[(E)-4-(2,3-
ihydrocinnamoyl oxy)-3-methyl-2-butenyl]-5-prenylphenyl}-2-
ropenoic acid; isosakuranetin; 3,5-diprenyl-4-hydroxycinnamic
cid also known by artepellin C; and kaempferide.
Dihydrokaempferide, a type of ﬂavonoid, was  the main active
ompound isolated from OEP, followed by kaempferide and
sosakuranetin, which showed potential antifungal activity against
. albicans (Finger et al., 2013). In addition to ﬂavonoids, sev-
ral prenylated phenolic acids were identiﬁed in OEP, such asand diazepam (DZP). *p < 0.05 compared to the control group treated with hydroal-
coholic solution plus Tween 80 (5%); #p < 0.05 compared to the DZP group; +p < 0.05
compared to the OEP 50 mg/kg group (ANOVA, Tukey’s test).
3,4-dihydroxy-5-prenyl-cinnamic acid, 3-prenyl-4-hydroxycinn-
amic acid and (E)-3-{4-hydroxy-3-[(E)-4-(2,3-dihydrocinnamoy-
loxy)-3-methyl-2-butenyl]-5-prenyl-phenyl}-2-propenoic acid. In
addition, we  suggested that OEP has several advantages over the
common EEP, such as the possibility of new pharmaceutical presen-
tations for topical or internal applications. Because of the absence
of ethanol in its formulation, edible OEP is expected to be better
tolerated (Finger et al., 2013).
Although the biological activities of propolis have been
described (Menezes, 2005; Alencar et al., 2007; Carvalho et al.,
2011), its effects on the CNS as a neuroprotector and causative agent
of alterations in behavior has been poorly described (Shimazawa
et al., 2005; Nakajima et al., 2007; Izuta et al., 2008; Lee et al., 2013).
In this study, we demonstrated that acute OEP administration intests and is associated with an increase in spontaneous locomotor
behavior. Anxiolytic-like activity began at doses of 10 mg/kg,
similar to the DZP group. However, at doses of 30 and 50 mg/kg,
1470 J.S.S. Reis et al. / Phytomedicine 21 (2014) 1466–1472
Fig. 4. Immobility time (panel A) and number of climbing events (panel B) of rats
tested in the Forced Swim test (FS) for 5 min. Each value represents the mean (S.E.M.)
of  8–10 animals (females). Groups: control; oil extract of propolis (OEP) at doses of
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Fig. 5. Determination of TEAC (panel A) and NO (panel B) in blood samples of rats
subjected to the forced swim test for 5 min. Each value represents the mean (S.E.M.)
of  8–10 animals. Groups: control (basal); BTS (Behavioral Training Stress) treated0 mg/kg, 30 mg/kg, and 50 mg/kg; and diazepam (DZP). *p < 0.05 compared to the
ontrol group treated with hydroalcoholic solution plus Tween 80 (5%) (ANOVA,
ukey’s test).
his effect was more pronounced than that of the DZP group. These
ata indicate that OEP is more potent than a classic anxiolytic drug
y the parameters measured in the OF test, such as the amount
f time spent in the central area and reduced grooming. Despite
he potent anxiolytic-like effect, the dose of 50 mg/kg resulted in
yperlocomotion, which was evident by the increased ambulation
easured in the arena. These ﬁndings showed that the OEP had
nxiolytic-like effects at all dosages tested and in both the OF and
PM models in a manner similar to the positive control, DZP.
Recently, Li et al. (2012), reported that propolis essential oil
PEO) at a dose of 100 mg/kg can readily mitigate anxiety-like
ehavior and inhibit hypothalamic-pituitary-adrenal (HPA) axis
yperactivity and lipid peroxidation in brain tissue. However, in
he spontaneous locomotor activity test, PEO showed no signif-
cant effect on motor parameters, which indicated the ability of
he essential oil to mitigate anxiety without causing sedation.
hese authors also showed that the PEO signiﬁcantly decreased
he plasma levels of cortisol (CORT), adrenocorticotropic hor-
one (ACTH) and malondialdehyde (MDA), whereas it increased
he activity of superoxide dismutase (SOD) in restraint-stressed
ice. Thus, these data strongly suggest that PEO has therapeu-
ic effects on anxiety through antagonizing the hyperfunction of
ypothalamic-pituitary-adrenal (HPA) axis and enhancing antiox-
dation mechanisms in brain tissue (Li et al., 2012).
Prut and Belzung (2003), reported that anxiolytic-like drugs
nduce an increase in central locomotion in animals. In addition,
ther authors showed that these drugs diminish grooming in the
F test (Moody et al., 1993; Prut and Belzung, 2003). Our results
emonstrated that 50 mg/kg OEP promotes an increase in loco-
otion during the OF test that is similar to the DZP group. These
esults are different from those of others who used protocols with
EP and PEO (Li et al., 2012; Lee et al., 2013). The mechanism ofwith saline; and BTS treated with oil extract of propolis (OEP). *p < 0.05 compared
to  the control group, without stress; #p < 0.05 compared to the BTS group (ANOVA,
Tukey’s test).
action involved in this effect needs to be elucidated. Altogether, our
results suggest that the effect of OEP is related to its anxiolytic-like
property because it diminishes risk-avoidance behavior, promoting
exploration of the environment.
In addition, our data showed that the OEP has antidepressant-
like activity in depressive-like rat models (Porsolt swim test).
Similarly, Lee et al. (2013), reported that the EEP also showed
antidepressant-like activity without locomotor alteration in the OF
test starting at 100 mg/kg. This dose was  higher than that used in
our study, which started at 30 mg/kg. However, in the Lee protocol,
propolis did not alter spontaneous locomotion in the OF  mod-
els, while in our study an increase in locomotion was  noted at a
dose of 50 mg/kg. These authors also suggested that the mecha-
nisms of the antidepressant effect might be related to modulation
of the hypothalamic-pituitary-adrenal (HPA) axis mediated by an
increase in glucocorticoid receptor (GR) function. This receptor
plays an important role in the therapeutic action antidepressants
(Lee et al., 2013). Our study demonstrated that OEP produces higher
effects in the CNS than the EEP tested by Lee and colleagues. How-
ever, this difference may  be because the chemical composition of
propolis may  be different, and the extraction solvent might also
affect the potency of the activity in the CNS. Vegetable oils should be
more effective than ethanol in extracting the lipophilic substances
of propolis, which are capable of crossing the blood–brain barrier
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Carvalho et al., 2011). In this regard, some studies showed that the
otency of biological activities depends on the quantitative com-
osition of the extracts, which is strongly inﬂuenced by the solvent
nd the experimental variables during extraction (Sawaya et al.,
002, 2011; Finger et al., 2013).
Neurodegenerative diseases can result in neuronal cell death
nduced by different causes, such as excitotoxicity, oxidative stress,
nﬂammation and apoptosis (Kumar et al., 2010). In addition, pre-
ious studies suggested that neurotic and anxious individuals tend
o be exposed to high levels of oxidative stress, and clinical trials
lso indicated higher levels of MDA  in patients with affective dis-
rders (Ozcan et al., 2004; Matsushita et al., 2010). In this study,
e showed that OEP demonstrated antioxidant action, inhibiting
itric oxide levels without altering the total antioxidant status in
ats exposed to BTS (Fig. 5). CNS tissue is particularly vulnerable
o oxidative damage, and propolis exerts an antioxidant effect in
he in vivo model of cerebral injury. The antioxidant properties of
ropolis extracts may  be related to their chemical composition,
uch as the content of ﬂavonoids (including ﬂavones, ﬂavonols,
avanones and dihydroﬂavonols) and other phenolic compounds
mainly substituted cinnamic acids and their esters) (Moreno et al.,
000; Banskota et al., 2001; Kumazawa et al., 2004). These prop-
rties have been assessed through different chemical assays, such
s DPPH radical and superoxide anion scavenging assays (Banskota
t al., 2000; Russo et al., 2004; Izuta et al., 2009) and determination
f the inhibition of DNA cleavage induced by hydrogen peroxide
Russo et al., 2004).
In terms of CNS activity, several studies have demonstrated
hat the caffeic acid phenethyl ester (CAPE) found in propo-
is has neuroprotective potential against the oxidative damage
nduced by ischemia–reperfusion and cytotoxic, inﬂammatory
nd autoimmune processes (Wei  et al., 2004; Ilhan et al.,
004; Tsai et al., 2006). Some studies showed that CAPE and
lpha-tocopherol suppressed ischemia–reperfusion-induced cere-
ral lipid peroxidation and injury. CAPE protected the spinal cord
rom ischemia–reperfusion injury (Ilhan et al., 1999; Irmak et al.,
003). Other studies reported that CAPE was able to inhibit reac-
ive oxygen species (ROS) production at the transcriptional level
hrough the suppression of nuclear factor kappa B (NF-B) acti-
ation and by directly inhibiting inducible nitric oxide synthase
iNOS) (Ilhan et al., 2004). In addition, Wei  et al. (2004), showed that
APE blocks hypoxia–ischemia-induced neuronal death through
nhibiting inﬂammation and mitochondrial cytochrome C release.
urthermore, CAPE was  also found to downregulate the expres-
ion of c-fos, that is a conventional marker for neuronal activation
Noh et al., 2012) involved in dysfunction of HPA axis and related
o behavior disorders, which may  explain the antidepressant-like
ctivity observed (Ha et al., 2009). The suppression of c-fos induced
y propolis may  be indicative of the complex behavioral responses
licited by behavioral tests such as the FS test. This observation
ay  provide insights into the neural circuits that may  be involved
n mediating the HPA axis response to the stress induced by the
ehavior test, mainly through the release of neurochemical medi-
tors (Lee et al., 2013). In this regard, previous studies have shown
hat elevated corticosterone levels in response to stress are corre-
ated with increased c-fos expression. Antidepressant drugs reduce
-fos protein overproduction and decrease neural activity, modu-
ating HPA-axis activity (Yau et al., 1995; De Kloet et al., 1998). In
ddition, western blot analysis revealed that there was a molecu-
ar link between the antidepressant-like activity of propolis extract
nd GR function in the hippocampus (Lee et al., 2013).
Other studies found that ﬂavonoids were able to promote the
aintenance and functionality of the substantia nigra pars compacta
nd striatum in rodents administered 6-hydroxydopamine (6-
HDA) in a Parkinson’s disease model (Youdim et al., 2001; Youdim
nd Stephenson, 2004). Orsatti and Sforcin (2012), observed thate 21 (2014) 1466–1472 1471
propolis exerts immunomodulatory activity in chronically stressed
mice, upregulating Toll-like receptor (TLR)-2 and TLR-4 mRNA
expression. These receptors are known pattern recognition recep-
tors (PRRs) of the innate immune system that initiate and propagate
an inﬂammatory response, inducing the synthesis and release
of cytokines, crossing blood–brain barrier and affecting struc-
tures related to behavior, such as the hippocampus and amygdala.
Pro-inﬂammatory cytokine inhibition blocks disorders behaviors.
Together, these data suggest that the immune system plays a
role in the brain in terms of behavioral regulation, possibly con-
nected to survival. Thus, drugs with anti-inﬂammatory activities
may  have behavioral effects through modulation of immune path-
ways (Orsatti and Sforcin, 2012).
Conclusion
In conclusion, our data showed that OEP exerted hyperlocomo-
tor and anxiolytic- and antidepressant-like effects in the CNS in
different animal models. Moreover, the extract also showed antiox-
idant activity after stress induced by the forced swim test.
Conﬂict of interest
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